HomepagePRGO • NYSE
add
Perrigo
$Â 9,30
Na sluitingstijd:(1,18%)+0,11
$Â 9,41
Gesloten: 13 mrt, 19:43:29 GMT-4 · USD · NYSE · Disclaimer
Vorige slotkoers
$Â 9,42
Dag-range
$Â 9,23 - $Â 9,77
Jaar-range
$Â 9,23 - $Â 29,08
Beurswaarde
1,28Â mld. USD
Gem. volume
3,30Â mln.
Koers/winst
-
Dividendrendement
12,47%
Primaire beurs
NYSE
In het nieuws
Financiële informatie
Resultatenrekening
Opbrengst
Netto inkomsten
| (USD) | dec 2025info | Wijziging j-o-j |
|---|---|---|
Opbrengst | 1,11Â mld. | -2,52% |
Bedrijfskosten | 215,40Â mln. | -12,83% |
Netto inkomsten | -1,42Â mld. | -3.086,74% |
Netto winstmarge | -127,80 | -3.168,54% |
Winst per aandeel | 0,77 | -17,20% |
EBITDA | 232,70Â mln. | 6,21% |
Effectief belastingtarief | -6,23% | — |
Balans
Totale activa
Totale passiva
| (USD) | dec 2025info | Wijziging j-o-j |
|---|---|---|
Contanten en kortetermijnbeleggingen | 531,60Â mln. | -4,87% |
Totale activa | 8,54Â mld. | -11,53% |
Totale passiva | 5,60Â mld. | 5,09% |
Totaal aandelenvermogen | 2,94 mld. | — |
Uitstaande aandelen | 137,65 mln. | — |
Koers-boekwaardeverhouding | 0,44 | — |
Rendement op activa | 3,94% | — |
Rendement op kapitaal | 4,86% | — |
Kasstroom
Nettomutatie in liquide middelen
| (USD) | dec 2025info | Wijziging j-o-j |
|---|---|---|
Netto inkomsten | -1,42Â mld. | -3.086,74% |
Operationele kasstroom | 175,40Â mln. | -43,89% |
Kasstroom uit beleggingen | -24,50Â mln. | 33,96% |
Kasstroom uit financiering | -54,40Â mln. | 95,29% |
Nettomutatie in liquide middelen | 99,50Â mln. | 111,00% |
Vrije kasstroom | 187,15Â mln. | -57,09% |
Over
Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters in Grand Rapids, Michigan, within Michigan State University's Grand Rapids Innovation Park.
Perrigo engages in the acquisition, manufacture, and sale of consumer healthcare products, generic prescription drugs, and active pharmaceutical ingredients, primarily in the United States, from its base in Ireland. On 21 December 2018, Perrigo suffered its biggest one-day share price fall in its history after the Irish Revenue Commissioners issued a tax claim against Perrigo that equated to half of its market value. Wikipedia
Opgericht
1887
Website
Werknemers
8.100